SCHEMBL20340441

SCHEMBL20340441

O=C1OCC2(CCCCC2)N1c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 3/20 0.46
LMNA P02545 2/20 0.41
GAA P10253 2/20 0.41
ALOX12 P18054 1/20 0.41
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
MMP13 P45452 1/20 0.36
HSD11B1 P28845 1/20 0.35
ALDH1A1 P00352 4/20 0.35
ATM Q13315 1/20 0.35
HTR1A P08908 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17149455 0.84 TSHR (0.46) IDH1SMN1; SMN2MMP13ALDH1A1MEN1
Hydrochloric Acid SCHEMBL17140395 0.83 TSHR (0.45) IDH1SMN1; SMN2MMP13ALDH1A1MEN1
SCHEMBL17513782 0.80 IDH1 (0.42) IDH1LMNAALDH1A1HPGD
SCHEMBL29348936 0.79 MMP13 (0.40) IDH1MMP13HSD11B1HSD17B10
SCHEMBL29348952 0.75 MMP13 (0.42) IDH1MMP13HSD11B1MEN1KMT2A
SCHEMBL5418053 0.74 IDH1 (0.38) IDH1ALDH1A1ATM
SCHEMBL3570167 0.72 IDH1 (0.38) IDH1HSD11B1ALDH1A1
SCHEMBL2725134 0.72 GRIN1 (0.35) IDH1GAAMAPTHSD11B1ALDH1A1
SCHEMBL19093367 0.71 LMNA (0.45) LMNAGAAALOX12MAPTSMN1; SMN2
Methane SCHEMBL3623097 0.71 GRIN1 (0.34) IDH1MAPTHSD11B1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10011601-B2 Substituted spirocyclic inhibitors of autotaxin X-RX, INC. (US) 2018-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10011601-B2 Substituted spirocyclic inhibitors of autotaxin ENPP2, SLC10A1, CXCR3 IDH1 2459/4885LMNA 3178/4885GAA 1645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.